Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of Recombinant Human Platelet-Activating Factor Acetylhydrolase for the Treatment of Severe Sepsis
This study has been terminated.
Study NCT00037687   Information provided by ICOS Corporation
First Received: May 20, 2002   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sepsis
More general conditions related to this trial
Infection
Inflammation
Pathologic Processes
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
rPAF-AH
Sponsors listed in this trial
ICOS Corporation
Suntory Pharmaceutical


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services